Insider Transactions in Q4 2020 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 30
2020
|
Felicia F Norwood EVP & President,Gov Health Ben |
SELL
Payment of exercise price or tax liability
|
Direct |
1,753
-9.64%
|
$550,442
$314.05 P/Share
|
|
Dec 30
2020
|
Prakash R Patel EVP & President, DBG |
SELL
Payment of exercise price or tax liability
|
Direct |
465
-3.85%
|
$146,010
$314.05 P/Share
|
|
Dec 30
2020
|
Leah Stark EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
328
-2.67%
|
$102,992
$314.05 P/Share
|
|
Dec 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
5,833
-5.24%
|
$1,819,896
$312.73 P/Share
|
|
Dec 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
5,833
+13.16%
|
$851,618
$146.93 P/Share
|
|
Dec 08
2020
|
John E Gallina EVP & Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
2,589
-6.19%
|
-
|
|
Dec 01
2020
|
Blair Williams Todt EVP, CLO & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
797
+50.0%
|
-
|
|
Dec 01
2020
|
Gail Boudreaux President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,764
-21.6%
|
$4,621,132
$313.9 P/Share
|
|
Nov 16
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
5,834
-2.32%
|
$1,942,722
$333.9 P/Share
|
|
Nov 16
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
1,708
+2.2%
|
$210,084
$123.85 P/Share
|
|
Nov 09
2020
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
1,199
-27.08%
|
$395,670
$330.75 P/Share
|
|
Nov 03
2020
|
Thomas C Zielinski EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
9,175
-10.2%
|
$2,679,100
$292.35 P/Share
|
|
Nov 03
2020
|
Thomas C Zielinski EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,893
+8.73%
|
$439,176
$232.04 P/Share
|
|
Oct 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
5,834
-2.42%
|
$1,703,528
$292.05 P/Share
|
|
Oct 15
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
4,667
+9.87%
|
$466,700
$100.77 P/Share
|
|
Oct 09
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
1,167
-2.98%
|
$344,265
$295.0 P/Share
|
|
Oct 02
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
SELL
Open market or private sale
|
Direct |
4,667
-10.66%
|
$1,306,760
$280.0 P/Share
|
|
Oct 02
2020
|
Peter D Haytaian EVP & Pres Carelon & CarelonRx |
BUY
Exercise of conversion of derivative security
|
Direct |
4,667
+5.19%
|
$443,365
$95.11 P/Share
|
|
Oct 01
2020
|
Jeffrey D. Alter EVP, IngenioRx & Anthem Health |
BUY
Grant, award, or other acquisition
|
Direct |
2,746
+50.0%
|
-
|